Brandina Ricardo, Berger Andre, Kamoi Kazumi, Gill Inderbir S
Department of Urology, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Curr Opin Urol. 2009 May;19(3):290-6. doi: 10.1097/MOU.0b013e328329a356.
To perform a contemporary critical appraisal of robotic-assisted radical prostatectomy (RaRP) through a review of the recent literature.
Most studies of RaRP are observational and report perioperative, functional and short-term oncological outcomes. RaRP is associated with less blood loss and blood transfusion than open radical prostatectomy (ORP), has a positive margin rate of 9.4-20.9%, potency rate of 79.2-80.4% at 1 year and a continence rate of 90.2-97% at 1 year. Costs of the da Vinci system remain a limitation of this technique.
RaRP has shown rapid dissemination over the past few years in the US urological community. However, prospective randomized clinical trials with long-term follow-up of RaRP, ORP and laparoscopic radical prostatectomy are still necessary.
通过回顾近期文献，对机器人辅助根治性前列腺切除术（RaRP）进行当代批判性评估。
大多数关于RaRP的研究为观察性研究，并报告围手术期、功能和短期肿瘤学结果。与开放性根治性前列腺切除术（ORP）相比，RaRP的失血量和输血较少，切缘阳性率为9.4 - 20.9%，1年时性功能保留率为79.2 - 80.4%，1年时控尿率为90.2 - 97%。达芬奇系统的成本仍然是该技术的一个限制因素。
在过去几年中，RaRP在美国泌尿外科领域迅速普及。然而，仍有必要对RaRP、ORP和腹腔镜根治性前列腺切除术进行长期随访的前瞻性随机临床试验。
Zotero 插件